Volume 11, Number 10—October 2005
Research
Vancomycin and Home Health Care
Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*
Table 2
Comparison of HICPAC guidelines with home infusion use of vancomycin in 296 patients*
| No. (%) | |
|---|---|
| Manner in which vancomycin use met guidelines | 180 (60.8) |
| Treatment of infections with β-lactam-resistant, gram-positive bacteria | 118 (65.6) |
| Treatment of gram-positive infections in patients with allergies to β-lactam agents | 67 (37.2) |
| Manner in which vancomycin use did not meet guidelines | 116 (39.2) |
| Continued empiric vancomycin use in patients with negative or no cultures | 84 (72.4) |
| Use of vancomycin for dosing convenience | 18 (15.5) |
| Prolonged administration of antimicrobial drugs after implantation of prosthetic materials or devices | 13 (11.2) |
| Treatment of a single blood culture showing coagulase-negative staphylococci | 9 (7.8) |
*Some patients fulfilled >1 criteria. HICPAC, Hospital Infection Control Practices Advisory Committee.
1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.